The Third Department of Surgery, The Fourth Hospital of Hebei Medical University, 050019 Shijiazhuang, China.
The Third Department of Surgery, The Fourth Hospital of Hebei Medical University, 050019 Shijiazhuang, China.
Biomed Pharmacother. 2022 Sep;153:113370. doi: 10.1016/j.biopha.2022.113370. Epub 2022 Jul 2.
Gastrointestinal (GI) cancers, one of the most lethal cancers nowadays, have caused millions of deaths. The tumor microenvironment (TME) is a complex ecosystem containing multiple cells, such as immune cells, cancer cells, and endothelial cells. Tumor-associated macrophages (TAMs), the predominant cells infiltrating the TME, have been verified to play a crucial role in regulating tumor progression. Noncoding RNAs (ncRNAs) are involved in mediating tumor-infiltrating immune cells, including TAMs. GI cancer cells produce various ncRNAs to modulate TAM infiltration and polarization. Meanwhile, ncRNAs play a pivotal role in macrophage and cancer cell metabolic reprogramming. Furthermore, macrophages mediate the impact of ncRNAs on chemoresistance, metastasis, and progression of GI cancer. In this review, we summarize recent research advances in the crosstalk between macrophages and GI cancer regulated by ncRNAs. Moreover, we propose the promising role of ncRNAs as potential targets and prognostic biomarkers in cancer treatment, hoping to facilitate the identification of new targets for immunotherapy.
胃肠道(GI)癌症是当今最致命的癌症之一,已经导致数百万人死亡。肿瘤微环境(TME)是一个包含多种细胞的复杂生态系统,如免疫细胞、癌细胞和内皮细胞。肿瘤相关巨噬细胞(TAMs)是浸润 TME 的主要细胞,已被证实在调节肿瘤进展中发挥关键作用。非编码 RNA(ncRNA)参与调节肿瘤浸润免疫细胞,包括 TAMs。GI 癌细胞产生各种 ncRNA 来调节 TAM 的浸润和极化。同时,ncRNA 在巨噬细胞和癌细胞的代谢重编程中发挥关键作用。此外,巨噬细胞介导 ncRNA 对 GI 癌症的化疗耐药性、转移和进展的影响。在这篇综述中,我们总结了 ncRNA 调控下巨噬细胞与胃肠道癌症相互作用的最新研究进展。此外,我们提出了 ncRNA 作为癌症治疗中潜在靶点和预后生物标志物的有前途的作用,希望有助于确定新的免疫治疗靶点。